Resize Text +/- -A +A

Your participation in our Geographic Atrophy clinical research study is appreciated

Thank you for participating in the Geographic Atrophy (GA) clinical research studies. By completing these studies, we will learn more about GA and a possible treatment option that may benefit you and others in the future.

Watch our videos to learn more ›

What is GA?

Geographic Atrophy is an advanced form of age-related macular degeneration. It is a progressive, irreversible condition of the eye that causes severe vision loss. GA damages the part of the eye that is responsible for sight in the center of your field of vision.

I know someone with GA

Caring for a loved one with GA can be challenging, but there are a variety of tools and resources available that can help ease the burden. Learn More ›

Clinical research studies for GA

The purpose of these studies is to understand the effects of an investigational drug called lampalizumab in reducing the speed of GA progression. Currently, these two clinical research studies (Chroma and Spectri) have completed recruitment.

  • Current Studies

    See about studies actively recruiting participants.

  • Talk to Your Doctor

    Our discussion guides help you understand what to expect during your visit.

  • Patient Resources

    There are a variety of resources available to help make living with GA easier.

Before you proceed

The link you selected will take you away from this site to one that is not owned or controlled by Genentech. Genentech is not part of the site, nor does it control the content. Genentech does not guarantee the information on the page. Your use of third-party websites is at your own risk and is subject to the third-party's privacy policy and terms and conditions for the use of such sites.

Before you proceed

The information contained in this section of the site is intended for healthcare professionals only. Select "Continue" if you are a healthcare professional.